Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
34,11 USD | +1,10% | -3,01% | +17,86% |
Omzet 2024 * | 603 mln. 559 mln. | Omzet 2025 * | 622 mln. 576 mln. | Marktkapitalisatie | 1,87 mld. 1,73 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 14 mln. 12,97 mln. | Nettowinst (verlies) 2025 * | 5 mln. 4,63 mln. | EV/omzet 2024 * | 3,1 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 3 x |
K/w-verhouding 2024 * |
620
x | K/w-verhouding 2025 * |
341
x | Werknemers | 652 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,88% |
Recentste transcriptie over Supernus Pharmaceuticals, Inc.
1 dag | +1,10% | ||
1 week | -3,01% | ||
Lopende maand | +14,85% | ||
1 maand | +9,75% | ||
3 maanden | +15,90% | ||
6 maanden | +21,47% | ||
Lopend jaar | +17,86% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 30-03-05 |
Timothy Dec
DFI | Director of Finance/CFO | 66 | 23-08-21 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-01-05 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 64 | 23-03-15 |
Charles Newhall
CHM | Chairman | 79 | 30-03-05 |
John Siebert
BRD | Director/Board Member | 84 | 01-01-11 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.94% | 29 M€ | +0,33% | ||
0.94% | 17 M€ | -0,46% | ||
0.38% | 26 M€ | +0,78% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 34,11 | +1,10% | 491 007 |
27-03-24 | 33,74 | +3,88% | 363 964 |
26-03-24 | 32,48 | -0,82% | 611 763 |
25-03-24 | 32,75 | -5,13% | 366 595 |
22-03-24 | 34,52 | -1,85% | 492 786 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,86% | 1,87 mld. | |
+13,53% | 76,83 mld. | |
+13,52% | 9,63 mld. | |
-7,87% | 5,37 mld. | |
+12,50% | 4,28 mld. | |
+18,09% | 3,71 mld. | |
+42,95% | 2,91 mld. | |
-19,01% | 2,54 mld. | |
-20,66% | 2,37 mld. | |
-8,99% | 1,65 mld. |